Compounds > pixantrone
Page last updated: 2024-09-04

pixantrone and pci 32765

pixantrone has been researched along with pci 32765 in 2 studies

Compound Research Comparison

Studies
(pixantrone)		Trials
(pixantrone)		Recent Studies (post-2010)
(pixantrone)		Studies
(pci 32765)		Trials
(pci 32765)		Recent Studies (post-2010) (pci 32765)
9216591,9262431,895

Protein Interaction Comparison

ProteinTaxonomypixantrone (IC50)pci 32765 (IC50)
Testosterone 17-beta-dehydrogenase 3Rattus norvegicus (Norway rat)0.0028
Solute carrier family 22 member 3Homo sapiens (human)7.9
Epidermal growth factor receptorHomo sapiens (human)0.0402
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.0104
Cytochrome P450 1A2Homo sapiens (human)0.019
Tyrosine-protein kinase LckHomo sapiens (human)0.018
Tyrosine-protein kinase FynHomo sapiens (human)0.096
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)5.545
Tyrosine-protein kinase YesHomo sapiens (human)0.0065
Tyrosine-protein kinase LynHomo sapiens (human)0.2
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.0262
Tyrosine-protein kinase HCKHomo sapiens (human)0.0095
Cytochrome P450 3A4Homo sapiens (human)0.089
Tyrosine-protein kinase FgrHomo sapiens (human)0.0021
Cytochrome P450 2C8Homo sapiens (human)3.9595
Cytochrome P450 2D6Homo sapiens (human)0.0769
Cytochrome P450 2C9 Homo sapiens (human)6.0643
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.0768
Cytochrome P450 2B6Homo sapiens (human)0.101
Cytochrome P450 2C19Homo sapiens (human)0.0769
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.073
Tyrosine-protein kinase CSKHomo sapiens (human)0.0023
Tyrosine-protein kinase TecHomo sapiens (human)0.0092
Tyrosine-protein kinase TXKHomo sapiens (human)0.0025
Tyrosine-protein kinase FRKHomo sapiens (human)0.0541
Tyrosine-protein kinase BlkHomo sapiens (human)0.0004
Cytoplasmic tyrosine-protein kinase BMXHomo sapiens (human)0.002
Tyrosine-protein kinase JAK3Homo sapiens (human)0.0411
Tyrosine-protein kinase BTKHomo sapiens (human)0.0422
Tyrosine-protein kinase ITK/TSKHomo sapiens (human)0.0471
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)4.4
Protein-tyrosine kinase 6Homo sapiens (human)0.018
Receptor tyrosine-protein kinase erbB-4Homo sapiens (human)0.0066
Nuclear receptor subfamily 4 group A member 3Homo sapiens (human)0.078
Peroxiredoxin-like 2AHomo sapiens (human)0.9
Platelet glycoprotein VIHomo sapiens (human)0.12

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Długosz-Danecka, M; Jurczak, W; Rivas Navarro, F1
Bertoni, F; Cascione, L; Gaudio, E; Stathis, A; Tarantelli, C; Zucca, E1

Reviews

1 review(s) available for pixantrone and pci 32765

ArticleYear
The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma: ten questions.
    Future oncology (London, England), 2019, Volume: 15, Issue:3

    Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Immunotherapy, Adoptive; Isoquinolines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Piperidines; Pyrazoles; Pyrimidines; Rituximab; Salvage Therapy; Stem Cell Transplantation

2019

Other Studies

1 other study(ies) available for pixantrone and pci 32765

ArticleYear
In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas.
    British journal of haematology, 2019, Volume: 186, Issue:1

    Topics: Adenine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Humans; Isoquinolines; Lymphoma; Piperidines; Purines; Pyrazoles; Pyrimidines; Quinazolinones

2019